2013 was the best year for the US IPO market since 2000. Against a favorable backdrop marked by a rising stock market, low interest rates, reduced volatility and increased risk tolerance among investors, a total of 222 companies went public and raised $55...read more
For the fifth consecutive week, at least one US IPO gained 30%, as Gigamon (GIMO) climbed nearly 50%. The week's most prominent IPO, Coty (COTY), faltered though, and the third scheduled deal, Aratana Therapeutics (PETX) was delayed. Nine more IPOs,...read more
Coty, a fragrance and cosmetics company with several globally recognized brands, raised $1.0 billion by offering 57.1 million shares at $17.50, within the range of $16.50 to $18.50. Coty plans to list on the NYSE under the symbol COTY. BofA Merrill Lynch, J.P....read more
The following IPOs are expected to price this week: Aratana Therapeutics (PETX), which is developing medications for cats and dogs based on therapies for human, plans to raise $51 million by offering 4.3 million shares at a price range of $11.00 to $13.00. ...read more
Renaissance Capital's 2013 US IPO Annual Review
2013 was the best year for the US IPO market since 2000. Against a favorable backdrop marked by a rising stock market, low interest rates, reduced volatility and increased risk tolerance among investors, a total of 222 companies went public and raised $55...read more
US IPO Recap: Coty fades, Gigamon springs and 17 companies file or set terms
For the fifth consecutive week, at least one US IPO gained 30%, as Gigamon (GIMO) climbed nearly 50%. The week's most prominent IPO, Coty (COTY), faltered though, and the third scheduled deal, Aratana Therapeutics (PETX) was delayed. Nine more IPOs,...read more
Coty prices IPO at $17.50, within the range
Coty, a fragrance and cosmetics company with several globally recognized brands, raised $1.0 billion by offering 57.1 million shares at $17.50, within the range of $16.50 to $18.50. Coty plans to list on the NYSE under the symbol COTY. BofA Merrill Lynch, J.P....read more
3 US IPOs planned for the week of Jun 10
The following IPOs are expected to price this week: Aratana Therapeutics (PETX), which is developing medications for cats and dogs based on therapies for human, plans to raise $51 million by offering 4.3 million shares at a price range of $11.00 to $13.00. ...read more